首页> 美国卫生研究院文献>Eye >Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?

【2h】

Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?

机译：哪种视敏度测量定义了兰尼单抗治疗的新血管性年龄相关性黄斑变性患者的高质量护理？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

PurposeThe purpose of this study is to define which visual acuity (VA) measurements are the best indicators of high-quality care for patients receiving intravitreal ranibizumab for neovascular age-related macular degeneration (nAMD).

机译：目的本研究的目的是确定哪些视力（VA）测量值是接受玻璃体腔内雷珠单抗治疗新血管性年龄相关性黄斑变性（nAMD）的患者高质量护理的最佳指标。

著录项

期刊名称 Eye
作者
A H Ross; P H J Donachie; A Sallam; I M Stratton; Q Mohamed; P H Scanlon; J N Kirkpatrick; R L Johnston;
展开▼
作者单位

展开▼
年(卷),期 2013(27),1
年度 2013
页码 56–64
总页数 9
原文格式 PDF
正文语种
中图分类眼科学;
关键词
ranibizumab visual acuity age-related macular degeneration neovascular;

机译：雷珠单抗;视力;年龄相关性黄斑变性;新生血管;

相似文献

外文文献
中文文献
专利

1. Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab? [J] . RossA.H., DonachieP.H.J., SallamA., Eye . 2013,第1期

机译：哪种视敏度测量定义了兰尼单抗治疗的新血管性年龄相关性黄斑变性患者的高质量护理？
2. Two year visual outcomes in patients with neovascular age-related macular degeneration treated with ranibizumab stratified by patient age and baseline visual acuity [J] . Hearne Elewys, Afshar Farid, Fletcher Emily, Investigative ophthalmology & visual science . 2016,第12期

机译：用患者年龄和基线视力分层治疗的新生血管年龄相关黄斑化患者的两年视觉结果
3. Refractory subretinal fluid in patients with neovascular age-related macular degeneration treated with intravitreal ranibizumab: visual acuity outcome [J] . Jang Liuna, Gianniou Christina, Ambresin Aude, Graefe's archive for clinical and experimental ophthalmology: Albrecht von Graefes Archiv fur klinische und experimentelle Opthalmologie . 2015,第8期

机译：玻璃体腔注射兰尼单抗治疗新生血管性年龄相关性黄斑变性的难治性视网膜下液：视力预后
4. Expression Pattern of Kinin-Dependent Genes in Peripheral Blood Mononuclear Cells After Age-Related Macular Degeneration Treatment with Ranibizumab [C] . Michalska-Malecka K, Strzalka-Mrozik B., Kimsa M.W., International Symposium on Ocular Pharmacology and Therapeutics . 2013

机译：与RANIBIZIMAB的年龄相关黄斑治疗后外周血单核细胞在外周血单核细胞中的表达模式
5. Associations among comorbidities, visual acuity, and quality of life in patients with age-related macular degeneration and central vision loss. [D] . Miskala, Paivi Helena. 2002

机译：与年龄相关的黄斑变性和中心视力丧失的患者的合并症，视敏度和生活质量之间的关联。
6. Neovascular age-related macular degeneration: is it worthwhile treating an eye with poor visual acuity if the visual acuity of the fellow eye is good? [O] . A Rasmussen, J Fuchs, L H Hansen, 2017

机译：新血管性年龄相关性黄斑变性：如果另一只眼的视力良好是否值得治疗视力不好的眼睛？
7. Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab? [O] . Ross, AH, Donachie, PH, Sallam, A, 2013

机译：哪种视敏度测量定义了兰尼单抗治疗的新血管性年龄相关性黄斑变性患者的高质量护理？

Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅